InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Roo5guy Free
12/17/12 7:58 AM
profile icon
mrholty Free
02/03/11 7:38 PM
profile icon
mkinhaw Free
12/16/09 1:51 PM
profile icon
mlkrborn Free
11/19/09 1:36 PM
profile icon
mlkrborn Free
10/29/09 7:08 PM
profile icon
Jim Sandres Free
01/02/09 8:39 PM
profile icon
edogg Free
01/02/09 4:03 PM
profile icon
sea_devil Free
12/19/08 4:07 PM
profile icon
sea_devil Free
12/19/08 3:39 PM
profile icon
sea_devil Free
12/19/08 1:09 PM
profile icon
sea_devil Free
12/17/08 7:49 PM
profile icon
surf1944 Free
05/14/08 8:27 AM
profile icon
surf1944 Free
05/12/08 9:05 AM
profile icon
surf1944 Free
04/30/08 8:09 AM
profile icon
surf1944 Free
04/16/08 7:58 AM
profile icon
surf1944 Free
02/16/08 4:06 PM
profile icon
surf1944 Free
12/12/07 11:03 AM
profile icon
surf1944 Free
12/05/07 8:08 AM
profile icon
surf1944 Free
12/03/07 7:07 PM
profile icon
surf1944 Free
12/03/07 7:55 AM
profile icon
surf1944 Free
12/02/07 9:54 AM
profile icon
surf1944 Free
12/01/07 7:09 PM
profile icon
surf1944 Free
12/01/07 7:04 PM

Neurobiological Technologies Inc. (NTII) RSS Feed

Followers
2
Posters
9
Posts (Today)
0
Posts (Total)
24
Created
12/01/07
Type
Free
Moderators
http://www.ntii.com/ http://www.ntii.com/wt/page/prod_pipeline http://finance.yahoo.com/q/sec?s=NTII http://www.form4oracle.com/company?cik=0000918112&ticker=ntii Neurobiological Technologies, Inc. (NTI) (NASDAQ: NTII) is a biotechnology company engaged in the business of acquiring and developing central nervous system (CNS) related drug candidates. The company is focused on therapies for neurological conditions that occur in connection with dementia, Alzheimer's disease, ischemic stroke, neuropathic pain, and brain cancer. The company employs a strategy of in-licensing late-stage CNS agents and pursues regulatory approval and commercialization either independently or with a strategic partner.
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
NTII Latest News
  • No Recent News Available for this company!
New Post